NCT04121156View on ClinicalTrials.gov

High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

HD-tDCS treatment

2 milli Amp dose of HD-tDCS treatment for for 20 minutes, for 5 consecutive twice daily sessions

DEVICE

sham (placebo) HD-tDCS

Participants will receive sham (placebo) HD-tDCS for 20 minutes, for 5 consecutive twice daily sessions

Trial Locations (1)

813

Department of Psychiatry, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter